Medical Management of Headache and Facial Pain in CRS : A Systematic Review and Meta‐Analysis
The Laryngoscope · 2024
DOI: 10.1002/lary.31502 ↗Kurz gefasst
Metaanalyse in der Zeitschrift The Laryngoscope, 2024. Verfasst von Luke D Heiland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A. Hauptthemen laut MEDLINE: Facial Pain, Headache, Rhinosinusitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Objectives
This study aims to characterize the effect of medical therapy on headache and facial pain/pressure among patients with chronic rhinosinusitis (CRS). Data Sources CINAHL, PubMed, and Scopus.
Methods
CINAHL, PubMed, and Scopus were searched from inception through April 10th, 2024, for English language articles reporting headache or facial pain/pressure outcomes in CRS patients. Inclusion was restricted to studies reporting results of the medical treatment of CRS in nonsurgical cohorts. Primary outcome measures included the sino‐nasal outcome test (SNOT) and the visual analogue scale (VAS). Meta‐analyses of continuous measures (mean), mean difference (Δ), and proportions (%) were conducted.
Results
The initial search yielded 2429 unique articles. After a full‐text review of 272 articles, 17 studies reporting outcomes for 2269 patients were included in the meta‐analysis. The mean patient age was 48.6 years (range 18.0–86.0; 95% CI: 46.5 to 50.6), among which 55.4% (95% CI: 51.5 to 59.4) were male and 82.9% (95% CI: 68.8 to 93.4) had nasal polyposis. SNOT facial pain/pressure scores improved by 1.1 points (95% CI: −1.7 to −0.5; relative reduction 40.4%) with non‐biologic therapies and 1.0 point (95% CI: −1.4 to −0.6; relative reduction 54.6%) with biologic therapies. On an 11‐point scale, VAS headaches scores improved by 1.8 units (95% CI: −3.3 to −0.3; 42.1% relative reduction) in CRSwNP patients and 1.0 unit (95% CI: −1.7 to −0.3; 54.0% relative reduction) in CRSsNP patients.
Conclusions
Our findings suggest medical therapy significantly reduces facial pain and pressure in the CRS population. Laryngoscope , 134:4458–4465, 2024
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, U.S.A.
- Saint Louis University School of Medicine, St. Louis, Missouri, U.S.A.
ORCID-Profile: Luke D Heiland, Alejandro R Marrero-Gonzalez, Shaun A Nguyen, Vinay K Rathi, Zachary M Soler
Zitieren
APA
Heiland, L. D., Marrero-Gonzalez, A. R., Nguyen, S. A., Farmer, H. G., Rathi, V. K., Soler, Z. M., & Schlosser, R. J. (2024). Medical Management of Headache and Facial Pain in CRS : A Systematic Review and Meta‐Analysis. The Laryngoscope. https://doi.org/10.1002/lary.31502
Vancouver
Heiland LD, Marrero-Gonzalez AR, Nguyen SA, Farmer HG, Rathi VK, Soler ZM, et al. Medical Management of Headache and Facial Pain in CRS : A Systematic Review and Meta‐Analysis. The Laryngoscope. 2024. doi:10.1002/lary.31502
BibTeX
@article{Heiland2024,
author = {Heiland, Luke D and Marrero-Gonzalez, Alejandro R and Nguyen, Shaun A and Farmer, Hannah G and Rathi, Vinay K and Soler, Zachary M and Schlosser, Rodney J},
title = {Medical Management of Headache and Facial Pain in CRS : A Systematic Review and Meta‐Analysis},
journal = {The Laryngoscope},
year = {2024},
doi = {10.1002/lary.31502}
}
EUVIMED